Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

$29M OFFERING BY ADVANCED TISSUE

Feb. 18, 1992

LIPO FILES TO OFFER 3M SHARES

Feb. 18, 1992

TRANSGENIC DEVELOPER MAKING IPO .

Feb. 18, 1992

CYTOTHERAPEUTICS FILES FOR IPO

Feb. 18, 1992

PRIVATE PLACEMENT RAISES $11.6M

Feb. 18, 1992

AMOCO UNIT ACQUIRES ECOVA CORP

Feb. 18, 1992

FDA APPROVES COMBINATION HIV TEST

Feb. 18, 1992

NEORX LICENSES PRE-TARGETING TECHNOLOGY

Feb. 18, 1992

COURT DISMISSES CENTOCOR SUIT

Feb. 18, 1992

HYCOR GETS HISTAMINE TECHNOLOGY

Feb. 18, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...